Misoprostol For Nulliparous Women Before Hysteroscopy

Wenzhou Medical University

Status and phase: Unknown; Phase 3

Conditions: Cervical Ripening

Treatments: Drug: misoprostol; Drug: oral misoprostol

Study type: Interventional

Funder types: Other

Identifiers

NCT01156948

WenzhouMC

Details and patient eligibility

About

To compare the impact of 400-microgram self-administered vaginal versus self-administered oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to outpatient hysteroscopy.

Full description

There is no consensus on the effect of misoprostol on cervical ripening for nulliparous women. The aim of the study is to compare the impact of 400-microgram self-administered vaginal versus self-administered oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to outpatient hysteroscopy.

Enrollment: 120 estimated patients

Sex: Female

Ages: 16 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• nulliparous women who are referred to outpatient hysteroscopy and who have given informed consent will be eligible for study recruitment.

Exclusion criteria

• women with a known allergy to misoprostol.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

120 participants in 2 patient groups

vaginal misoprostol

Active Comparator group

Description:

vaginal misoprostol was administered to this group of nulliparous women

Treatment:

Drug: misoprostol

oral misoprostol

Experimental group

Description:

oral misoprostol

Treatment:

Drug: oral misoprostol